Anebulo Pharmaceuticals Inc ANEB:NASDAQ

RT Quote | Last NASDAQ LS, VOL From CTA | USD
Last | 4:00 PM EDT
2.20quote price arrow down-0.16 (-6.78%)
Volume
11,655
52 week range
1.62 - 4.05
Loading...
  • Open2.23
  • Day High2.44
  • Day Low2.20
  • Prev Close2.36
  • 52 Week High4.05
  • 52 Week High Date09/12/23
  • 52 Week Low1.62
  • 52 Week Low Date10/16/23

Key Stats

  • Market Cap57.053M
  • Shares Out25.93M
  • 10 Day Average Volume0.01M
  • Dividend-
  • Dividend Yield-
  • Beta-0.99
  • YTD % Change-8.68

KEY STATS

  • Open2.23
  • Day High2.44
  • Day Low2.20
  • Prev Close2.36
  • 52 Week High4.05
  • 52 Week High Date09/12/23
  • 52 Week Low1.62
  • 52 Week Low Date10/16/23
  • Market Cap57.053M
  • Shares Out25.93M
  • 10 Day Average Volume0.01M
  • Dividend-
  • Dividend Yield-
  • Beta-0.99
  • YTD % Change-8.68

RATIOS/PROFITABILITY

  • EPS (TTM)-0.41
  • P/E (TTM)-5.38
  • Fwd P/E (NTM)-8.84
  • EBITDA (TTM)-10.663M
  • ROE (TTM)-95.37%
  • Revenue (TTM)-
  • Gross Margin (TTM)-
  • Net Margin (TTM)-
  • Debt To Equity (MRQ)-

EVENTS

  • Earnings Date09/18/2024(est)
  • Ex Div Date-
  • Div Amount-
  • Split Date-
  • Split Factor-

Latest On Anebulo Pharmaceuticals Inc

 

Content From Our Affiliates

There is no recent news for this security.

Profile

MORE
Anebulo Pharmaceuticals, Inc. is a clinical-stage biotechnology company. The Company is engaged in developing novel solutions for people suffering from acute cannabinoid intoxication (ACI) and substance addiction. The Company’s lead product candidate is ANEB-001, a potent, small molecule antagonist of cannabinoid binding receptor type-1 (CB1), the primary receptor involved in the psychotropic effects of cannabinoids, with the potential to address the unmet medical need for a...
Address
Jfl Capital Management
1017 Rr 620 S, Suite 107
Lakeway, TX
78734
United States

Top Peers

SYMBOLLASTCHG%CHG
SLS
Sellas Life Sciences Group Inc
1.47UNCHUNCH
CGTX
Cognition Therapeutics Inc
1.94-0.01-0.51%
CVM
CEL-SCI Corp
1.40-0.04-2.78%
RLYB
Rallybio Corp
1.86-0.05-2.62%
ALRN
Aileron Therapeutics Inc
3.85-0.05-1.28%